通过光蛋白组学来确定三阴性乳腺癌的治疗策略

Yuhan Sheng1,2, Gordon Mills1, Xuejiao Zhao1,3

  • 1Division of Oncological Sciences Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.

Expert review of proteomics
|November 26, 2024
PubMed
概括

蛋白组学通过揭示治疗点,为三阴性乳腺癌 (TNBC) 提供了新的希望. 将这些先进的分析纳入临床实践可以显著改善患者的治疗结果和生存率.